| 缩写名/全名 |
CURR PHARM BIOTECHNO
CURRENT PHARMACEUTICAL BIOTECHNOLOGY |
||||||||||||||||||||
| ISSN号 | 1389-2010 | ||||||||||||||||||||
| 研究方向 | 医学-生化与分子生物学 | ||||||||||||||||||||
| 影响因子 | 2015:1.802, 2016:2.459, 2017:1.819, 2018:1.516, 2019:2.097, | ||||||||||||||||||||
| 出版国家 | UNITED STATES | ||||||||||||||||||||
| 出版周期 | Bimonthly | ||||||||||||||||||||
| 年文章数 | 118 | ||||||||||||||||||||
| 出版年份 | 2000 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 一般,3-6周 |
||||||||||||||||||||
| 录用比例 | 容易 | ||||||||||||||||||||
| 投稿链接 | http://benthamscience.com/journal/authors-guidelines.php?journalID=cpb#top | ||||||||||||||||||||
| 投稿官网 | http://benthamscience.com/journal/index.php?journalID=cpb | ||||||||||||||||||||
| h-index | 73 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1389-2010%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Establishment of Novel Cells Stably Secreting Various Human IL-18 Recombinant Proteins. Author: Kumagai A1, Shimizu K2, Kurata R3, Cui X4, Isagawa T5, Harada M1,6, Nagai J1, Yoshida Y7, Ozaki KI3, Takeda N8, Semba H9, Yonezawa T1. Journal: Curr Pharm Biotechnol. 2019;20(1):47-55. doi: 10.2174/1389201020666190206203640. PubMed DOI |
| 2. | In vivo Evaluation and Alzheimer's Disease Treatment Outcome of siRNA Loaded Dual Targeting Drug Delivery System. Author: Zhang C1, Gu Z1, Shen L2, Liu X1, Lin H1. Journal: Curr Pharm Biotechnol. 2019;20(1):56-62. doi: 10.2174/1389201020666190204141046. PubMed DOI |
| 3. | Computer-Assisted Drug Virtual Screening Based on Natural Product Databases. Author: Yang B1, Gao B2, Lu X1, Mao J1. Journal: Curr Pharm Biotechnol. 2019 Mar 27. doi: 10.2174/1389201020666190328115411. [Epub ahead of print] PubMed DOI |
| 4. | Tanshinone IIA promotes macrophage cholesterol efflux and attenuates atherosclerosis of apoE-/- mice by Omentin-1/ABCA1 pathway. Author: Tan YL1, Ou HX2, Zhang M1, Gong D1, Zhao ZW1, Chen LY1, Xia XD1, Mo ZC2, Tang CK1. Journal: Curr Pharm Biotechnol. 2019 Apr 4. doi: 10.2174/1389201020666190404125213. [Epub ahead of print] PubMed DOI |
| 5. | Ideal and Reality: Barricade in the Delivery of Small Interfering RNA for Cancer Therapy. Author: Wu D, Han H, Xing Z, Zhang J, Li L, Shi W, Li Q. Journal: Curr Pharm Biotechnol. 2016;17(3):237-47. PubMed |
| 6. | Cytotoxic Nitrobenzoyloxy-substituted Sesquiterpenes from Spongederived Endozoic Fungus Aspergillus insulicola MD10-2. Author: Zhao HY, Anbuchezhian R, Sun W, Shao CL, Zhang FL, Yin Y, Yu ZS, Li ZY, Wang CY. Journal: Curr Pharm Biotechnol. 2016;17(3):271-4. PubMed |
| 7. | Editorial: Polymeric Nanomedicines for Malignancy Therapy. Author: Ding J, Zhuang X, Chen X. Journal: Curr Pharm Biotechnol. 2016;17(3):210-1. No abstract available. PubMed |
| 8. | Acidity-Activated Shielding Strategies of Cationic Gene Delivery for Cancer Therapy. Author: Xia J, Feng Z, Yang H, Lin S, Han B. Journal: Curr Pharm Biotechnol. 2016;17(3):256-62. PubMed |
| 9. | Salvianolic Acid A Attenuates Cell Apoptosis, Oxidative Stress, Akt and NF-κB Activation in Angiotensin-II Induced Murine Peritoneal Macrophages. Author: Li L, Xu T, Du Y, Pan D, Wu W, Zhu H, Zhang Y, Li D. Journal: Curr Pharm Biotechnol. 2016;17(3):283-90. PubMed |
| 10. | Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer. Author: Liu D, Wang X, Chen Z. Journal: Curr Pharm Biotechnol. 2016;17(6):486-94. PubMed |
|
|
